- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 29, 2026 | 390.26M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 328.29M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 303.63M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $253.17M |
| Capex | Q1 2026 · Mar 31, 2025 | $161.24M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.19B |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$428.61M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $2.05B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $2.05B |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $0 |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $631.09M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $700.36M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $997.83M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$351.37M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $717.29M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $3.18B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $3.87B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.69B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $2.64B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $5.45B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $5.39B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.76B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $3.3B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $7.48B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $8.39B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$3.46 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$2.41 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$3.46 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$2.41 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $304.18M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $212.18M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $335.67M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $251.25M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.03B |
| Net Income | Q1 2026 · Mar 31, 2025 | −$366.17M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$989.49M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$691.93M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $594.17M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $463.56M |
| Revenue | Q1 2026 · Mar 31, 2026 | $282.47M |
| Revenue | Q1 2026 · Mar 31, 2025 | $235.05M |